Published January 2018 | Version v1
Journal article

Activated protein C protects against pressure overload-induced hypertrophy through AMPK signaling

  • 1. Department of Physiology and Biophysics, Mississippi Center for Heart Research, University of Mississippi Medical Center, Jackson, MS 39216 (United States)
  • 2. Department of Pharmacology and Toxicology, SUNY Buffalo, Buffalo, NY 14214 (United States)
  • 3. The First Affiliated Hospital, Jilin University, Changchun 130012 (China)
  • 4. School of Life Sciences, Lanzhou University, Lanzhou 730000 (China)
  • 5. Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104 (United States)

Description

Highlights: • Cardiac AMPK protects against pressure overload-induced hypertrophy. • The signaling function of APC protects against pressure overload-induced hypertrophy. • APC decreases inflammatory reactions and cardiac ROS generation induced by pressure overload. We found that the anticoagulant plasma protease, activated protein C (APC), stimulates the energy sensor kinase, AMPK, in the stressed heart by activating protease-activated receptor 1 (PAR1) on cardiomyocytes. Wild-type (WT) and AMPK-kinase dead (KD) transgenic mice were subjected to transverse aortic constriction (TAC) surgery. The results demonstrated that while no phenotypic differences can be observed between WT and AMPK-KD mice under normal physiological conditions, AMPK-KD mice exhibit significantly larger hearts after 4 weeks of TAC surgery. Analysis by echocardiography suggested that the impairment in the cardiac function of AMPK-KD hearts is significantly greater than that of WT hearts. Immunohistochemical staining revealed increased macrophage infiltration and ROS generation in AMPK-KD hearts after 4 weeks of TAC surgery. Immunoblotting results demonstrated that the redox markers, pShc66, 4-hydroxynonenal and ERK, were all up-regulated at a higher extent in AMPK-KD hearts after 4 weeks of TAC surgery. Administration of APC-WT and the signaling selective APC-2Cys mutant, but not the anticoagulant selective APC-E170A mutant, significantly attenuated pressure overload-induced hypertrophy and fibrosis. Macrophage infiltration and pShc66 activation caused by pressure overload were also inhibited by APC and APC-2Cys but not by APC-E170A. Therefore, the cardiac AMPK protects against pressure overload-induced hypertrophy and the signaling selective APC-2Cys may have therapeutic potential for treating hypertension-related hypertrophy without increasing the risk of bleeding.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2017.12.125

Additional details

Identifiers

DOI
10.1016/j.bbrc.2017.12.125;
PII
S0006291X17325251;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
495
Journal Issue
4
Journal Page Range
p. 2584-2594
ISSN
0006-291X
CODEN
BBRCA9

INIS

Optional Information

Copyright
Copyright (c) 2017 Elsevier Inc. All rights reserved.